ChemPartner Receives 2009 Most Valuable Partner (MVP) Award from Roche R&D Center China (RRDCC)

SHANGHAI, Feb. 5 /PRNewswire-Asia/ -- Shanghai ChemPartner, a leading China-based contract research organization and a wholly owned subsidiary of ShangPharma, today announced that it had received the 2009 Most Valuable Partner (MVP) Award from Roche R&D Center China (RRDCC) for excellent service and outstanding contributions in the area of Oncology and Diabetes Pharmacology research, which have successfully helped advance the RRDCC drug discovery project milestones during 2009.

"We are very pleased with the collaboration with ChemPartner on biology research. Our R&D success today would be impossible without the excellent work of collaboration partners like you," Dr. Li Chen, CSO of RRDCC, commented at the award ceremony. "We are riding the same boat. Our collaboration is creating a new model of drug discovery in China."

"We are honored to receive this award and appreciate Roche China's recognition of the efforts and dedication of our talented team of scientists. This award reflects the value and capabilities of ChemPartner's service to our partners," commented Michael Hui, founder and CEO of ChemPartner.

"We will continue to focus on the quality of our science, project management and logistics, to add value for our partners R&D programs," Dr. Yuguang Wang, Senior VP of ChemPartner added. "We are also committed to provide intellectual contributions to our customers and partners by leveraging the R&D expertise of our scientific team."

RRDCC MVP awards are presented annually to partners who have done excellent work in collaboration with RRDCC. More than 20 external partners were evaluated in this award competition of 2009.

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including more than 100 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies. Headquartered in China, ChemPartner has overseas business development operations in Boston, USA and Copenhagen, Denmark.

About ShangPharma

ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides customized services to international pharmaceutical, biotech, agrochemical and chemical companies. As the holding company of Shanghai ChemPartner Co., Ltd., Shanghai ChemExplorer Company Ltd., China Gateway Pharmaceutical (Shanghai) Ltd. and China Gateway Pharma Products (Chengdu) Ltd., ShangPharma offers global pharmaceutical, biotechnology and chemical companies comprehensive services and materials for their research and development needs. ShangPharma currently has a team of more than 1,800 professionals, and more than 60% of the employees have post graduate educational experience of Master or Ph.D. degrees. ShangPharma has established comprehensive R&D partnerships with world-class academic institutes, universities as well as healthcare industry and organizations, to contribute more added-value for its clients' success.

    Further information is available at http://www.shangpharma.com.

    For more information, please contact:

    Media Contacts:
     Ms. Jasmine Luo
     Public Affairs Department
     Shanghai ChemPartner
     Tel:   +86-21-5137-0655
     Email: [email protected]

SOURCE Shanghai ChemPartner

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED